148 related articles for article (PubMed ID: 37266511)
1. Synthetic ditempolphosphatidylcholine liposome-like nanoparticles for anti-oxidative therapy of atherosclerosis.
Wang C; Zhao R; Wang Z; Xu T; Huang P
RSC Adv; 2023 May; 13(24):16211-16221. PubMed ID: 37266511
[TBL] [Abstract][Full Text] [Related]
2. Targeted Therapy of Atherosclerosis by a Broad-Spectrum Reactive Oxygen Species Scavenging Nanoparticle with Intrinsic Anti-inflammatory Activity.
Wang Y; Li L; Zhao W; Dou Y; An H; Tao H; Xu X; Jia Y; Lu S; Zhang J; Hu H
ACS Nano; 2018 Sep; 12(9):8943-8960. PubMed ID: 30114351
[TBL] [Abstract][Full Text] [Related]
3. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases.
Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H
Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099
[TBL] [Abstract][Full Text] [Related]
4. Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies.
Yuan J; Li L; Yang Q; Ran H; Wang J; Hu K; Pu W; Huang J; Wen L; Zhou L; Jiang Y; Xiong X; Zhang J; Zhou Z
ACS Nano; 2021 Oct; 15(10):16076-16094. PubMed ID: 34606239
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin.
Cheraga N; Ye Z; Xu MJ; Zou L; Sun NC; Hang Y; Shan CJ; Yang ZZ; Chen LJ; Huang NP
Nanoscale; 2022 Jun; 14(24):8709-8726. PubMed ID: 35673987
[TBL] [Abstract][Full Text] [Related]
6. A Broad-Spectrum ROS-Eliminating Material for Prevention of Inflammation and Drug-Induced Organ Toxicity.
Li L; Guo J; Wang Y; Xiong X; Tao H; Li J; Jia Y; Hu H; Zhang J
Adv Sci (Weinh); 2018 Oct; 5(10):1800781. PubMed ID: 30356945
[TBL] [Abstract][Full Text] [Related]
7. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
[TBL] [Abstract][Full Text] [Related]
8. Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression.
Cannizzo B; Quesada I; Militello R; Amaya C; Miatello R; Cruzado M; Castro C
Free Radic Res; 2014 May; 48(5):526-33. PubMed ID: 24490696
[TBL] [Abstract][Full Text] [Related]
9. A nanotherapy responsive to the inflammatory microenvironment for the dual-targeted treatment of atherosclerosis.
Li G; Xu F; Yang B; Lu X; Li X; Qi Y; Teng L; Li Y; Sun F; Liu W
Nanomedicine; 2022 Jul; 43():102557. PubMed ID: 35390526
[TBL] [Abstract][Full Text] [Related]
10. ROS-mediated liposomal dexamethasone: a new FA-targeted nanoformulation to combat rheumatoid arthritis
Song Y; Ismail M; Shan Q; Zhao J; Zhu Y; Zhang L; Du Y; Ling L
Nanoscale; 2021 Dec; 13(47):20170-20185. PubMed ID: 34846489
[TBL] [Abstract][Full Text] [Related]
11. The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.
Kim CH; Mitchell JB; Bursill CA; Sowers AL; Thetford A; Cook JA; van Reyk DM; Davies MJ
Atherosclerosis; 2015 May; 240(1):234-41. PubMed ID: 25818249
[TBL] [Abstract][Full Text] [Related]
12. Tempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria.
Francischetti IM; Gordon E; Bizzarro B; Gera N; Andrade BB; Oliveira F; Ma D; Assumpção TC; Ribeiro JM; Pena M; Qi CF; Diouf A; Moretz SE; Long CA; Ackerman HC; Pierce SK; Sá-Nunes A; Waisberg M
PLoS One; 2014; 9(2):e87140. PubMed ID: 24586264
[TBL] [Abstract][Full Text] [Related]
13. A novel antioxidant Mito-Tempol inhibits ox-LDL-induced foam cell formation through restoration of autophagy flux.
Ma Y; Huang Z; Zhou Z; He X; Wang Y; Meng C; Huang G; Fang N
Free Radic Biol Med; 2018 Dec; 129():463-472. PubMed ID: 30321700
[TBL] [Abstract][Full Text] [Related]
14. Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain.
Lochhead JJ; McCaffrey G; Sanchez-Covarrubias L; Finch JD; Demarco KM; Quigley CE; Davis TP; Ronaldson PT
Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H582-93. PubMed ID: 22081706
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.
Luo Y; Guo Y; Wang H; Yu M; Hong K; Li D; Li R; Wen B; Hu D; Chang L; Zhang J; Yang B; Sun D; Schwendeman AS; Eugene Chen Y
EBioMedicine; 2021 Dec; 74():103725. PubMed ID: 34879325
[TBL] [Abstract][Full Text] [Related]
16. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis.
Zhang Y; Yin Y; Zhang W; Li H; Wang T; Yin H; Sun L; Su C; Zhang K; Xu H
J Nanobiotechnology; 2021 May; 19(1):161. PubMed ID: 34059078
[TBL] [Abstract][Full Text] [Related]
17. Beneficial Effect of Tempol, a Membrane-Permeable Radical Scavenger, on Inflammation and Osteoarthritis in In Vitro Models.
Calabrese G; Ardizzone A; Campolo M; Conoci S; Esposito E; Paterniti I
Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33669093
[TBL] [Abstract][Full Text] [Related]
18. Design of a new self-assembling antioxidant nanomedicine to ameliorate oxidative stress in zebrafish embryos.
Shashni B; Tamaoki J; Kobayashi M; Nagasaki Y
Acta Biomater; 2023 Mar; 159():367-381. PubMed ID: 36640953
[TBL] [Abstract][Full Text] [Related]
19. Engineering ROS-scavenging Prussian blue nanozymes for efficient atherosclerosis nanotherapy.
Chen X; Dai C; Hu R; Yu L; Chen Y; Zhang B
J Mater Chem B; 2023 Mar; 11(9):1881-1890. PubMed ID: 36723250
[TBL] [Abstract][Full Text] [Related]
20. A novel anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier system: physical characterization and cellular uptake evaluation in vitro and in vivo.
Shi C; Gao F; Gao X; Liu Y
Biomed Pharmacother; 2015 Feb; 69():191-200. PubMed ID: 25661357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
